Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility

被引:46
作者
Valdezate, S
Vindel, A
Echeita, A
Baquero, F
Cantón, R
机构
[1] Hosp Ramon & Cajal, Microbiol Serv, E-28034 Madrid, Spain
[2] Inst Carlos III, Ctr Nacl Microbiol, Dept Bacteriol, Madrid 28220, Spain
关键词
D O I
10.1128/AAC.46.3.665-671.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The quinolone resistance-determining regions (QRDRs) of topoisomerase II and IV genes from Stenotrophomonas maltophilia ATCC 13637 were sequenced and compared with the corresponding regions of 32 unrelated S. maltophilia clinical strains for which ciprofloxacin MICs ranged from 0.1 to 64 mug/ml. GyrA (Leu-55 to Gln-155, Escherichia coli numbering), GyrB (Met-391 to Phe-513), ParC (Ile-34 to Arg-124), and ParE (Leu-396 to Leu-567) fragments from strain ATCC 13637 showed high degrees of identity to the corresponding regions from the phytopathogen Xylella fastidiosa, with the, degrees of identity ranging from 85.0 to 93.5%. Lower degrees of identity to the corresponding regions from Pseudomonas aeruginosa (70.9 to 88.6%) and E. coli (73.0 to 88.6%) were observed. Amino acid changes were, present in GyrA fragments from 9 of the 32 strains at positions 70, 85, 90, 103, 112, 113, 119, and 124; but there was no consistent relation to higher ciprofloxacin MICs. The absence of changes at positions 83 and 87, commonly involved in quinolone resistance in gram-negative bacteria, was unexpected. The GyrB sequences were identical in all strains, and only one strain (ciprofloxacin MIC, 16 mug/ml) showed a ParC amino acid change, (Ser-80-->Arg). In contrast, a high frequency (16 of 32 strains) of amino acid replacements was present in ParE. The frequencies of alterations at positions 437, 465, 477, and 485 were higher (P<0.05) in strains from cystic fibrosis patients, but these changes were not linked with high ciprofloxacin MICs. An efflux phenotype, screened by the detection of decreases of at least twofold doubling dilutions of the ciprofloxacin MIC in the presence of carbonyl cyanide m-chlorophenylhydrazone (0.5 mu g/ml) or reserpine (10 mu g/ml), was suspected in seven strains. These results suggest that topoisomerases II and IV may not be the primary targets involved in quinolone resistance in S. maltophilia.
引用
收藏
页码:665 / 671
页数:7
相关论文
共 42 条
[1]   Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia [J].
Alonso, A ;
Martinez, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1879-1881
[2]   Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis [J].
Bebear, CM ;
Renaudin, J ;
Charron, A ;
Renaudin, H ;
de Barbeyrac, B ;
Schaeverbeke, T ;
Bebear, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :954-956
[3]   Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases [J].
Bou, G ;
Cerveró, G ;
Domínguez, MA ;
Quereda, C ;
Martínez-Beltrán, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3299-3305
[4]   Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV [J].
Breines, DM ;
Ouabdesselam, S ;
Ng, EY ;
Tankovic, J ;
Shah, S ;
Soussy, CJ ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :175-179
[5]   EMERGENCE OF OFLOXACIN-RESISTANT CITROBACTER-FREUNDII AND PSEUDOMONAS-MALTOPHILIA AFTER OFLOXACIN THERAPY [J].
CHENG, AF ;
LI, MKW ;
LING, TKW ;
FRENCH, GL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (02) :283-285
[6]   CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES [J].
CULLEN, ME ;
WYKE, AW ;
KURODA, R ;
FISHER, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :886-894
[7]   Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae [J].
Dekitsch, C ;
Schein, R ;
Markopulos, E ;
Kuen, B ;
Graninger, W ;
Georgopoulos, A .
JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (01) :73-77
[8]   Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia [J].
Denton, M ;
Kerr, KG .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) :57-+
[9]   Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus:: Novel pleiotropic effects an quinolone and coumarin activity [J].
Fournier, B ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) :121-128
[10]   Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region [J].
Friedman, SM ;
Lu, T ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2378-2380